Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2139-2141

  Waites, Ken B ^a   Crabb, D M ^a   Duffy, Lynn B ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEM 101; CLINDAMYCIN; DOXYCYCLINE; KETOLIDE; LEVOFLOXACIN; LINEZOLID; TELITHROMYCIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; DRUG POTENCY; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA; MYCOPLASMA FERMENTANS; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; UREAPLASMA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA; MYCOPLASMA FERMENTANS; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE; UREAPLASMA; UREAPLASMA INFECTIONS;

EID: 66149134798     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00090-09     Document Type: Article

References (21)

1. Bebear, C. M., H. Renaudin, A. Charron, D. Gruson, M. Lefrancois, and C. Bebear. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob. Agents Chemother. 44:2557-2560.
2. Biedenbach, D. J., L. M. Deshpande, T. R. Fritsche, H. S. Sader, and R. N. Jones. 2008. Antimicrobial characterization of CEM-101: activity against enterococci, uncommon gram-positive pathogens, N. gonorrhoeae and anaerobes, abstr. F1-3976. 48th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
3. Duffy, L., J. Glass, G. Hall, R. Avery, R. Rackley, S. Peterson, and K. Waites. 2006. Fluoroquinolone resistance in Ureaplasma parvum in the United States. J. Clin. Microbiol. 44:1590-1591.
4. Jensen, J. S., C. S. Bradshaw, S. N. Tabrizi, C. K. Fairley, and R. Hamasuna. 2008. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 47:1546-1553.
5. Jones, R. N., D. J. Biedenbach, P. R. Rhomberg, T. R. Fritsche, and H. S. Sader. 2008. Antimicrobial characterization of CEM-101 activity against 331 respiratory tract pathogens including multidrug-resistant pneumococcal serogroup 19A (MDR-19A) isolates, abstr. F1-3975. 48th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
6. Liu, Y., X. Ye, H. Zhang, W. Li, D. Zhu, and M. Wang. 2008. In vitro antimicrobial susceptibility of Mycoplasma pneumoniae strains isolated from Shanghai, China, Abstr. 43. 17th Int. Org. Mycoplasmol. Congr., Tianjin, China, 6 to 11 July 2008.
7. Lonks, J. R., and D. A. Goldmann. 2005. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections. Clin. Infect. Dis. 40:1657-1664. (Pubitemid 40720819)
8. Matsuoka, M., M. Narita, N. Okazaki, H. Ohya, T. Yamazaki, K. Ouchi, I. Suzuki, T. Andoh, T. Kenri, Y. Sasaki, A. Horino, M. Shintani, Y. Arakawa, and T. Sasaki. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48:4624-4630.
9. McGhee, P., K. Nagai, and P. C. Appelbaum. 2008. Activity of CEM-101 compared to other agents against macrolide-susceptible and resistant streptotocci, abstr. F1-3974. 48th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
10. Morozumi, M., K. Hasegawa, R. Kobayashi, N. Inoue, S. Iwata, H. Kuroki, N. Kawamura, E. Nakayama, T. Tajima, K. Shimizu, and K. Ubukata. 2005. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob. Agents Chemother. 49:2302-2306.
11. Morozumi, M., S. Iwata, K. Hasegawa, N. Chiba, R. Takayanagi, K. Matsubara, E. Nakayama, K. Sunakawa, and K. Ubukata. 2008. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 52:348-350.
12. Pereyre, S., A. Charron, H. Renaudin, C. Bebear, and C. M. Bebear. 2007. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J. Clin. Microbiol. 45:3534-3539.
13. Roblin, P. M., S. A. Kohlhoff, and M. R. Hammerschlag. 2008. In vitro activity of CEM 101, a new ketolide antibiotic against Chlamydia trachomatis and Chlamydia pneumioniae, abstr. F1-3978. 48th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
14. Suzuki, S., T. Yamazaki, M. Narita, N. Okazaki, I. Suzuki, T. Andoh, M. Matsuoka, T. Kenri, Y. Arakawa, and T. Sasaki. 2006. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 50:709-712.
15. Waites, K. B., D. M. Crabb, and L. B. Duffy. 2003. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob. Agents Chemother. 47:39-42.
16. Waites, K. B., L. B. Duffy, D. F. Talkington, and S. B. Schwartz. 2004. Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma cultures from clinical specimens, p. 3.15.1-3.15.15. In H. Isenberg (ed.), Clinical microbiology procedure handbook, 2nd ed., vol.1. ASM Press, Washington, DC.
17. Waites, K. B., B. Katz, and R. L. Schelonka. 2005. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev. 18:757-789. (Pubitemid 41504514)
18. Waites, K. B., and D. F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17:697-728.
19. Waites, K. B., and D. Taylor-Robinson. 2007. Mycoplasma and Ureaplasma, p. 1004-1020. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed, vol.1. ASM Press, Washington, DC.
20. Wolff, B. J., W. L. Thacker, S. B. Schwartz, and J. M. Winchell. 2008. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high resolution melt analysis. Antimicrob. Agents Chemother. 52:3542-3549.
21. Xiao, L., T. P. Atkinson, J. Hagood, C. Makris, L. B. Duffy, and K. B. Waites. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr. Infect. Dis. J., in press.